Taro Pharmaceutical Industries

Text Size A A A

Url

Print Home » Url

Taro to Acquire Alchemee From Galderma

Submitted by tarocms on Tue, 02/22/2022 - 20:48

Read more about Taro to Acquire Alchemee From Galderma
Log in or register to post comments

Taro USA announces consumer recall for 1 lot of Clobetasol Propionate Ointment USP, 0.05% - Lot AC13786

Submitted by admin on Thu, 01/27/2022 - 11:02

Taro Launches Specialty Generic Deferiprone Tablets, 500mg in the U.S.

Submitted by tarocms on Mon, 09/28/2020 - 22:51

Read more about Taro Launches Specialty Generic Deferiprone Tablets, 500mg in the U.S.
Log in or register to post comments

Taro Achieves Global Resolution of DOJ Antitrust Investigations

Submitted by tarocms on Fri, 07/24/2020 - 02:06

Read more about Taro Achieves Global Resolution of DOJ Antitrust Investigations
Log in or register to post comments

Taro Appoints New Chief Financial Officer

Submitted by tarocms on Mon, 04/06/2020 - 23:10

Read more about Taro Appoints New Chief Financial Officer
Log in or register to post comments

Taro Pharmaceuticals U.S.A. Issues Voluntary Nationwide Recall of Phenytoin Oral Suspension USP, 125 mg/5 mL Due to Possible Underdosing or Overdosing

Submitted by tarocms on Fri, 02/21/2020 - 06:00

Taro Pharmaceuticals U.S.A., Inc. Issues Voluntary Nationwide Recall of Lamotrigine Tablets USP, 100 mg, 100 Count Bottles

Submitted by tarocms on Sat, 01/11/2020 - 01:38

Pages